NCT05997550Befejeződött
The Effect of Pursed Lip Breathing Exercise and Laughter Therapy Individuals With The COPD
The Effect of Pursed Lip Breathing Exercise and Laughter Therapy on Dyspnea, Health Status, and Care Dependence in Individuals With Chronic Obstructive Pulmonary Disease
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. febr. 3.
Rövid összefoglaló (regiszter, angolul)
Chronic Obstructive Pulmonary Disease is a chronic disease with increasing mortality, morbidity and prevalence in the world and in our country, and in which serious symptoms, especially dyspnea, develop. Due to dyspnea and symptoms, patients experience deterioration in their health status and an increase in care dependency. This research is a single-blind, randomized controlled experimental study designed to determine the effects of pursed lip breathing exercise and laughter therapy on dyspnea severity, health status and care dependence in individuals with COPD. The research will be carried out with a total of 63 patients in Ankara City Hospital Chest Diseases unit. The patients will be stratified according to smoking status and COPD Assessment Test scores with the randomization program and assigned to 2 intervention groups and 1 control group. During the first interview, patients in the 1st intervention group will be provided with pursed lip breathing exercise training and application, and training videos and brochures will be given. 2. The patients in the intervention group will be given laughter therapy training and practice, and an educational brochure will be given. The patients in the control group will also receive face-to-face training on lung structure and functioning, and a brochure will be given. Patients in the laughter therapy and pursed lip breathing exercise intervention groups will be asked to perform these practices three days a week (Monday, Wednesday, Friday) for 8 weeks. At the beginning of the study, at the 4th, 8th, and 12th weeks, the Dyspnea 12-TR Scale, the COPD Evaluation Test, and the Care Dependency Scale will be administered to both the intervention and control group patients. In the application of the scales and the analysis of the data, the groups will be blinded, and the scale application will be made by an independent interviewer. After the analysis of the data in terms of normal distribution was done with the Kolmogorow Smirnov test, in the comparison of the data of the patients in the intervention and control groups; One Way Analysis of Variance or Kruskal-Wallis Analysis of Variance will be applied. Analysis of Variance in Repeated Measurements or Freidman's test will be used to calculate the change in groups over time. The statistical significance limit will be accepted as p<0.05.
- Állapot (regiszter)
- Befejeződött
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 63 (tényleges)
- Első benyújtás
- 2023. jún. 16.
- Kezdés
- 2022. aug. 15.
- Elsődleges befejezés
- 2024. aug. 15.
- Fő szponzor
- Yuksek Ihtisas University
- Betegségek
- Krónikus obstruktív tüdőbetegség (COPD)
- NCT-szám
- NCT05997550
Mit vállalsz
- Vizsgálat típusa: Beavatkozással járó
- Bevont résztvevők: 63
- 2022. aug. 15. és az elsődleges befejezés (2024. aug. 15.) között
- 1 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Not complying with pursed lip breathing exercise and laughter therapy and program,
- Changes in bronchodilator and oxygen therapy regimens,
Más betegség
- Developing a disease that may affect the health status or a condition requiring hospitalization (COPD exacerbation, etc.) during the 12-week period during which the research will take place,
- A situation that is not suitable for laughter therapy due to the diagnosis of surgery in the abdominal region, uncontrollable hypertension, glaucoma, abdominal hernia, epilepsy,
Egyéb
- Patients who want to withdraw from the study are excluded from the study.
Kiket keres a vizsgálat
- Those aged 40 and over,
- He was diagnosed with COPD as a result of medical history, physical examination and pulmonary function tests, and his CAT score is 10 and above according to the COPD Unified Assessment* of the GOLD guide; In Group B and D (1),
- There is no diagnosis of a disease that may affect the cognitive state,
- Not having a diagnosis of a physical or mental illness that will prevent communication, and able to use a telephone.
- Individuals who agree to participate in the research are included in the study
- Non-Inclusion Criteria:
- Those who have difficulty in verbal communication (intubation, tracheostomy, delirium, etc.)
- With a CAT score of less than 10 and in Groups A and C according to the COPD Combined Assessment* of the GOLD guide,
- Having a disorder that disrupts the cognitive process such as schizophrenia or dementia
- Alcohol, substance addiction,
- Laughter therapy was not deemed appropriate due to the diagnosis of abdominal surgery, uncontrolled hypertension, glaucoma, abdominal hernia, epilepsy in the last three months,
- Using complementary and integrative treatments such as acupuncture, meditation, yoga, massage, relaxation exercises,
- Patients who do not agree to participate in the study are excluded from the study.
Életkor a regiszterben: 40 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Bilkent City Hospital | Ankara | Törökország | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.